Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biomedical Research

This article was originally published in SRA

Executive Summary

Government starts consultation on privacy rights in Singapore

Government starts consultation on privacy rights in Singapore

The government-appointed Bioethics Advisory Committee (BAC) of Singapore has published a consultation paper to assess opinion on how personal information should be protected and used in biomedical research. The consultation has been distributed to 70 organisations and the public are also encouraged to make submissions. The closing date for comments is 31 July 2006.

The paper splits its recommendations into seven separate sections as follows1,2:

  • legal protection of personal information;
  • informed consent;
  • epidemiological research and public health research;
  • clinical audit;
  • additional considerations about consent;
  • privacy and confidentiality; and
  • access to medical information by employers and insurers.

It is hoped that by developing a legal privacy protection regime Singapore will be brought into line with most other countries that conduct biomedical research. This could open up the door for potential international collaboration as well as other benefits.

References

1. Bioethics Advisory Committee press release, 14 June 2006, www.bioethics-singapore.org/media/press.html

2. The use of Personal Information in Biomedical Research: A consultation paper, 14 June 2006, www.bioethics-singapore.org/media/PI%20Consultation%20Paper.pdf

Latest Headlines
See All
UsernamePublicRestriction

Register

PS111396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel